• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于评分算法的肌张力障碍基因组检测:一项前瞻性验证研究。

Scoring Algorithm-Based Genomic Testing in Dystonia: A Prospective Validation Study.

机构信息

Institute of Neurogenomics, Helmholtz Zentrum München, Munich, Germany.

Institute of Human Genetics, Technical University of Munich, Munich, Germany.

出版信息

Mov Disord. 2021 Aug;36(8):1959-1964. doi: 10.1002/mds.28614. Epub 2021 May 5.

DOI:10.1002/mds.28614
PMID:33949708
Abstract

BACKGROUND

Despite the established value of genomic testing strategies, practice guidelines for their use do not exist in many indications.

OBJECTIVES

We sought to validate a recently introduced scoring algorithm for dystonia, predicting the diagnostic utility of whole-exome sequencing (WES) based on individual phenotypic aspects (age-at-onset, body distribution, presenting comorbidity).

METHODS

We prospectively enrolled a set of 209 dystonia-affected families and obtained summary scores (0-5 points) according to the algorithm. Singleton (N = 146), duo (N = 11), and trio (N = 52) WES data were generated to identify genetic diagnoses.

RESULTS

Diagnostic yield was highest (51%) among individuals with a summary score of 5, corresponding to a manifestation of early-onset segmental or generalized dystonia with coexisting non-movement disorder-related neurological symptoms. Sensitivity and specificity at the previously suggested threshold for implementation of WES (3 points) was 96% and 52%, with area under the curve of 0.81.

CONCLUSIONS

The algorithm is a useful predictive tool and could be integrated into dystonia routine diagnostic protocols. © 2021 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson Movement Disorder Society.

摘要

背景

尽管基因组检测策略具有既定的价值,但在许多情况下,其实践指南并不存在。

目的

我们旨在验证一种最近引入的用于预测基于个体表型特征(发病年龄、身体分布、伴发的合并症)的全外显子组测序(WES)诊断效用的肌张力障碍评分算法。

方法

我们前瞻性地招募了一组 209 个受肌张力障碍影响的家族,并根据该算法获得了综合评分(0-5 分)。对单卵(N=146)、双卵(N=11)和三卵(N=52)WES 数据进行了生成,以识别遗传诊断。

结果

综合评分最高(5 分)的个体的诊断率最高(51%),对应于早发性节段性或全身性肌张力障碍伴同时存在非运动障碍相关的神经系统症状的表现。先前建议实施 WES 的阈值(3 分)的敏感性和特异性为 96%和 52%,曲线下面积为 0.81。

结论

该算法是一种有用的预测工具,可整合到肌张力障碍的常规诊断方案中。© 2021 作者。运动障碍由 Wiley 期刊代表国际帕金森运动障碍协会出版。

相似文献

1
Scoring Algorithm-Based Genomic Testing in Dystonia: A Prospective Validation Study.基于评分算法的肌张力障碍基因组检测:一项前瞻性验证研究。
Mov Disord. 2021 Aug;36(8):1959-1964. doi: 10.1002/mds.28614. Epub 2021 May 5.
2
Increased diagnostic yield in complex dystonia through exome sequencing.通过外显子组测序提高复杂型肌张力障碍的诊断率。
Parkinsonism Relat Disord. 2020 May;74:50-56. doi: 10.1016/j.parkreldis.2020.04.003. Epub 2020 Apr 20.
3
Monogenic variants in dystonia: an exome-wide sequencing study.基因性肌张力障碍变异:外显子组测序研究。
Lancet Neurol. 2020 Nov;19(11):908-918. doi: 10.1016/S1474-4422(20)30312-4.
4
Nomenclature of Genetically Determined Myoclonus Syndromes: Recommendations of the International Parkinson and Movement Disorder Society Task Force.遗传性肌阵挛性癫痫综合征命名:国际运动障碍协会工作组推荐。
Mov Disord. 2019 Nov;34(11):1602-1613. doi: 10.1002/mds.27828. Epub 2019 Oct 4.
5
Whole exome sequencing and clinical investigation of young onset dystonia: What can we learn?全外显子组测序结合临床研究早发型肌张力障碍:我们能从中得到什么启示?
Parkinsonism Relat Disord. 2023 Oct;115:105814. doi: 10.1016/j.parkreldis.2023.105814. Epub 2023 Aug 17.
6
Molecular diversity of combined and complex dystonia: insights from diagnostic exome sequencing.联合型和复杂型肌张力障碍的分子多样性:来自诊断外显子组测序的见解。
Neurogenetics. 2017 Dec;18(4):195-205. doi: 10.1007/s10048-017-0521-9. Epub 2017 Aug 28.
7
Clinically relevant copy-number variants in exome sequencing data of patients with dystonia.肌张力障碍患者外显子测序数据中具有临床相关性的拷贝数变异
Parkinsonism Relat Disord. 2021 Mar;84:129-134. doi: 10.1016/j.parkreldis.2021.02.013. Epub 2021 Feb 12.
8
Biallelic AOPEP Loss-of-Function Variants Cause Progressive Dystonia with Prominent Limb Involvement.双等位基因AOPEP功能丧失变体导致以肢体明显受累为特征的进行性肌张力障碍。
Mov Disord. 2022 Jan;37(1):137-147. doi: 10.1002/mds.28804. Epub 2021 Oct 1.
9
Highlighting the Dystonic Phenotype Related to GNAO1.凸显与 GNAO1 相关的肌张力障碍表型。
Mov Disord. 2022 Jul;37(7):1547-1554. doi: 10.1002/mds.29074. Epub 2022 Jun 20.
10
Clinical exome sequencing in early-onset generalized dystonia and large-scale resequencing follow-up.早发性全身性肌张力障碍的临床外显子组测序和大规模重测序随访。
Mov Disord. 2017 Apr;32(4):549-559. doi: 10.1002/mds.26808. Epub 2016 Sep 26.

引用本文的文献

1
Genetic Diversity and Expanded Phenotypes in Dystonia: Insights From Large-Scale Exome Sequencing.肌张力障碍的遗传多样性与扩展表型:来自大规模外显子组测序的见解
Ann Clin Transl Neurol. 2025 Jun 18. doi: 10.1002/acn3.70100.
2
Barriers to clinical genetic testing in movement disorders.运动障碍临床基因检测的障碍
Curr Opin Neurol. 2025 Aug 1;38(4):355-360. doi: 10.1097/WCO.0000000000001381. Epub 2025 May 21.
3
Long-Read Sequencing: The Third Generation of Diagnostic Testing for Dystonia.长读长测序:肌张力障碍的第三代诊断检测方法
Mov Disord. 2025 Jun;40(6):1009-1019. doi: 10.1002/mds.30208. Epub 2025 Apr 23.
4
Insights on the Shared Genetic Landscape of Neurodevelopmental and Movement Disorders.神经发育障碍与运动障碍共享遗传图谱的见解。
Curr Neurol Neurosci Rep. 2025 Mar 17;25(1):24. doi: 10.1007/s11910-025-01414-w.
5
Combined genomics and proteomics unveils elusive variants and vast aetiologic heterogeneity in dystonia.基因组学和蛋白质组学相结合揭示了肌张力障碍中难以捉摸的变异和巨大的病因异质性。
Brain. 2025 Feb 12. doi: 10.1093/brain/awaf059.
6
Genetic Diversity and Expanded Phenotypes in Dystonia: Insights from Large-Scale Exome Sequencing.肌张力障碍的遗传多样性与扩展表型:来自大规模外显子组测序的见解
medRxiv. 2024 Dec 5:2024.12.02.24316741. doi: 10.1101/2024.12.02.24316741.
7
Dystonia: A novel sign of the Smith-Magenis syndrome - A three-case report.肌张力障碍:史密斯-马吉尼斯综合征的一种新体征——三例报告
Clin Park Relat Disord. 2024 Aug 6;11:100267. doi: 10.1016/j.prdoa.2024.100267. eCollection 2024.
8
Applicability of clinical genetic testing for deep brain stimulation treatment in monogenic Parkinson's disease and monogenic dystonia: a multidisciplinary team perspective.临床基因检测在单基因帕金森病和单基因肌张力障碍深部脑刺激治疗中的适用性:多学科团队视角
Front Neurosci. 2023 Nov 10;17:1282267. doi: 10.3389/fnins.2023.1282267. eCollection 2023.
9
Untangling neurodevelopmental disorders in the adulthood: a movement disorder is the clue.成年期神经发育障碍的厘清:运动障碍是关键。
Orphanet J Rare Dis. 2022 Feb 16;17(1):55. doi: 10.1186/s13023-022-02218-8.